Minatoya Kenji, Ogino Hitoshi, Matsuda Hitoshi, Sasaki Hiroaki, Tanaka Hiroshi, Kobayashi Junjiro, Yagihara Toshikatsu, Kitamura Soichiro
Department of Cardiovascular Surgery, National Cardiovascular Center, Suita, Osaka, Japan.
Ann Thorac Surg. 2008 Dec;86(6):1827-31. doi: 10.1016/j.athoracsur.2008.07.024.
Although hypothermic circulatory arrest (HCA) combined with selective cerebral perfusion (SCP) is a safe strategy for aortic arch surgery, neither the optimal temperature of hypothermia nor the optimal SCP flow rate has been clearly determined. We have since 2002 gradually elevated the temperature of HCA from 20 degrees C to 28 degrees C for aortic arch surgery. This study explored the impact of different temperatures during HCA with SCP on neurologic complications.
Since January 2002, 229 patients have undergone aortic arch replacement (mean age, 70.8 +/- 9.7 years; 156 male) with HCA and SCP through median sternotomy in our institution. Eighty-one patients were cooled to 20 degrees C (group A), 81 were cooled to 25 degrees C (group B), and 67 were cooled to 28 degrees C (group C). The brachiocephalic and left common carotid arteries were perfused separately during SCP in all cases. The left subclavian artery was additionally perfused in group C. Twenty-two operations in group A, 17 in group B, and 6 in group C were performed emergently (p = 0.58). The SCP flow rate was maintained at approximately 10 mL.kg(-1).min(-1) in groups A and B and approximately 15 mL.kg(-1).min(-1) in group C to keep blood pressure in the temporal artery at approximately 60 mm Hg.
The early mortality rate was 3.7% (3 of 81) in group A, 0% in group B, and 1.5% (1 of 67) in group C (p = 0.19). Postoperative stroke occurred in 2 patients (2.5%) in group A, in 3 (3.7%) in group B, and in 4 (6.0%) in group C (p = 0.55). Postoperative transient neurologic dysfunction occurred in 7 patients (8.6%) in group A, in 9 patients (11.1%) in group B, and in 4 patients (6.0%) in group C (p = 0.54). No patients in any group had postoperative paraplegia. The mean durations of circulatory arrest were 64 +/- 21 minutes in group A, 49 +/- 14 minutes in group B, and 46 +/- 13 minutes in group C (p < 0.0001). The mean durations of SCP were 145 +/- 67 minutes in group A, 116 +/- 48 minutes in group B, and 111 +/- 61 minutes in group C (p = 0.0007). Mean SCP flow rates were 8.8 +/- 1.9 mL.kg(-1).min(-1) in group A, 10.5 +/- 3.1 mL.kg(-1).min(-1) in group B, and 19.0 +/- 4.2 mL.kg(-1).min(-1) in group C (p < 0.0001).
The rate of postoperative neurologic events did not increase with use of higher temperature. The temperature during HCA could be safely increased to 28 degrees C with high SCP flow rate. Use of moderate HCA with SCP during aortic arch replacement permits radical reconstruction of the aortic arch and can avoid the need for deep hypothermia.
尽管低温循环停搏(HCA)联合选择性脑灌注(SCP)是主动脉弓手术的一种安全策略,但低温的最佳温度和SCP的最佳流速均尚未明确确定。自2002年以来,我们在主动脉弓手术中已将HCA的温度从20℃逐渐提高至28℃。本研究探讨了HCA期间不同温度联合SCP对神经并发症的影响。
自2002年1月起,我院229例患者通过正中胸骨切开术接受了HCA联合SCP的主动脉弓置换术(平均年龄70.8±9.7岁;男性156例)。81例患者被冷却至20℃(A组),81例被冷却至25℃(B组),67例被冷却至28℃(C组)。所有病例在SCP期间分别对头臂动脉和左颈总动脉进行灌注。C组还额外对左锁骨下动脉进行灌注。A组22例手术、B组17例手术和C组6例手术为急诊手术(p = 0.58)。A组和B组的SCP流速维持在约10 mL·kg⁻¹·min⁻¹,C组维持在约15 mL·kg⁻¹·min⁻¹,以使颞动脉血压维持在约60 mmHg。
A组早期死亡率为3.7%(81例中的3例),B组为0%,C组为1.5%(67例中的1例)(p = 0.19)。A组2例患者(2.5%)发生术后卒中,B组3例(3.7%),C组4例(6.0%)(p = 0.55)。A组7例患者(8.6%)发生术后短暂性神经功能障碍,B组9例(11.1%),C组4例(6.0%)(p = 0.54)。任何组均无患者发生术后截瘫。A组循环停搏的平均持续时间为64±21分钟,B组为49±14分钟,C组为46±13分钟(p < 0.0001)。A组SCP的平均持续时间为145±67分钟,B组为116±48分钟,C组为111±61分钟(p = 0.0007)。A组平均SCP流速为8.8±1.9 mL·kg⁻¹·min⁻¹,B组为10.5±3.1 mL·kg⁻¹·min⁻¹,C组为19.0±4.2 mL·kg⁻¹·min⁻¹(p < 0.0001)。
使用较高温度时术后神经事件发生率并未增加。HCA期间的温度可在高SCP流速下安全提高至28℃。在主动脉弓置换术中使用适度的HCA联合SCP可实现主动脉弓的根治性重建,并可避免深度低温的需要。